Bright Minds Biosciences Inc (XCNQ:DRUG) Stock News, Headlines & Updates
Bright Minds Biosciences Inc Stock News from GuruFocus
- 1
Jul 02, 2025
Bright Minds Biosciences (DRUG) Receives "Overweight" Rating from Cantor Fitzgerald | DRUG Stock News
GuruFocus News • 8:30am
May 28, 2025
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
Marketwired • 7:00am
May 21, 2025
Bright Minds Biosciences (DRUG) Receives Consistent 'Buy' Rating from Chardan Capital | DRUG Stock News
GuruFocus News • 9:31am
May 20, 2025
Bright Minds (DRUG) Schedules Virtual R&D Day to Discuss Epilepsy Breakthroughs | DRUG Stock News
GuruFocus News • 7:32am
Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025
Marketwired • 7:00am
May 13, 2025
TD Cowen Initiates Coverage on Bright Minds Biosciences (DRUG) with Buy Rating | DRUG Stock News
GuruFocus News • 11:31am
Bright Minds (DRUG) Reports Promising Results in Epilepsy Research | DRUG Stock News
GuruFocus News • 8:20am
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
Marketwired • 8:00am
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101 | DRUG Stock News
GuruFocus News • 7:52am
Bright Minds (DRUG) Gains 'Buy' Rating from TD Cowen Analyst | DRUG Stock News
GuruFocus News • 4:45am
May 07, 2025
Bright Minds Biosciences (DRUG) Receives Buy Rating from Chardan Capital | DRUG Stock News
GuruFocus News • 6:01am
Bright Minds (DRUG) Receives Buy Rating from Chardan Analyst | DRUG Stock News
GuruFocus News • 4:15am
Apr 28, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news